Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 3
2019 1
2020 6
2021 16
2022 12
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
Roccuzzo G, Calvão J, Dobos G, Morsia E, Mozas P, Peterknecht E, Schrader AMR, Zottarelli F, Bagot M, Stadler R, Vermeer M, Quaglino P, Scarisbrick J. Roccuzzo G, et al. Among authors: mozas p. Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093/bjd/ljae145. Online ahead of print. Br J Dermatol. 2024. PMID: 38576352 No abstract available.
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.
Mozas P, Casanueva-Eliceiry S, Rivero A, Serna Á, Simó M, Rodríguez S, Rivas-Delgado A, Nadeu F, Correa JG, Piñeyroa JA, Pérez-Valencia AI, Guinetti-Ortiz K, Gómez-Hernando M, Giné E, Delgado J, Villamor N, Campo E, Magnano L, Abrisqueta P, Setoain X, López-Guillermo A. Mozas P, et al. Hematol Oncol. 2024 Jan;42(1):e3235. doi: 10.1002/hon.3235. Epub 2023 Nov 9. Hematol Oncol. 2024. PMID: 37942762
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Martínez-Cibrián N, Ortiz-Maldonado V, Español-Rego M, Blázquez A, Cid J, Lozano M, Magnano L, Giné E, Correa JG, Mozas P, Rodríguez-Lobato LG, Rivero A, Montoro-Lorite M, Ayora P, Navarro S, Alserawan L, González-Navarro EA, Castellà M, Sánchez-Castañón M, Cabezón R, Benítez-Ribas D, Setoaín X, Rodríguez S, Brillembourg H, Varea S, Olesti E, Guillén E, Sáez-Peñataro J, de Larrea CF, López-Guillermo A, Pascal M, Urbano-Ispizua Á, Juan M, Delgado J. Martínez-Cibrián N, et al. Among authors: mozas p. Br J Haematol. 2024 Feb;204(2):525-533. doi: 10.1111/bjh.19170. Epub 2023 Oct 31. Br J Haematol. 2024. PMID: 37905734
MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms.
Fernández-Garnacho EM, Nadeu F, Martín S, Mozas P, Rivero A, Delgado J, Giné E, López-Guillermo A, Duran-Ferrer M, Salaverria I, López C, Beà S, Demajo S, Jares P, Puente XS, Martín-Subero JI, Campo E, Hernández L. Fernández-Garnacho EM, et al. Among authors: mozas p. Sci Rep. 2023 Oct 6;13(1):16839. doi: 10.1038/s41598-023-44174-8. Sci Rep. 2023. PMID: 37803049 Free PMC article.
All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia.
López-Oreja I, López-Guerra M, Correa J, Mozas P, Muntañola A, Muñoz L, Salgado AC, Ruiz-Gaspà S, Costa D, Beà S, Jares P, Campo E, Colomer D, Nadeu F. López-Oreja I, et al. Among authors: mozas p. Hemasphere. 2023 Sep 21;7(10):e962. doi: 10.1097/HS9.0000000000000962. eCollection 2023 Oct. Hemasphere. 2023. PMID: 37746159 Free PMC article. No abstract available.
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.
Syrykh C, Pons-Brun B, Russiñol N, Playa-Albinyana H, Baumann T, Duran-Ferrer M, Kulis M, Carbó-Meix A, Mozas P, Alcoceba M, González M, Navarro-Bailón A, Colado E, Payer ÁR, Aymerich M, Terol MJ, Lu J, Knisbacher BA, Hahn CK, Ruiz-Gaspà S, Enjuanes A, Wu CJ, Getz G, Zenz T, López-Guillermo A, Martín-Subero JI, Colomer D, Delgado J, Campo E, Nadeu F. Syrykh C, et al. Among authors: mozas p. Blood Adv. 2023 Dec 12;7(23):7384-7391. doi: 10.1182/bloodadvances.2023010132. Blood Adv. 2023. PMID: 37505099 Free PMC article. No abstract available.
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Muntañola A, Villalobos MT, González-Villambrosia S, Rodríguez-Salazar MJ, Jiménez-Ubieto A, Bastidas-Mora G, Córdoba R, Infante M, Vidal MJ, Díaz FJ, Baile M, Bastos-Oreiro M, Panizo C, Sancho JM, Navarro B, García T, Escoda L, Abrisqueta P, Terol MJ, de Campo R, Mozas P, López-Guillermo A, Salar A, Montalbán C; GELTAMO group (Grupo Español de Linfomas y Trasplante de Médula Ósea). Muntañola A, et al. Among authors: mozas p. Br J Haematol. 2023 Aug;202(4):776-784. doi: 10.1111/bjh.18912. Epub 2023 Jun 30. Br J Haematol. 2023. PMID: 37386877
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Mozas P, López C, Grau M, Nadeu F, Clot G, Valle S, Kulis M, Navarro A, Ramis-Zaldivar JE, González-Farré B, Rivas-Delgado A, Rivero A, Frigola G, Balagué O, Giné E, Delgado J, Villamor N, Matutes E, Magnano L, García-Sanz R, Huet S, Russell RB, Campo E, López-Guillermo A, Beà S. Mozas P, et al. Hematol Oncol. 2023 Oct;41(4):631-643. doi: 10.1002/hon.3132. Epub 2023 Mar 30. Hematol Oncol. 2023. PMID: 36994552
Lesions mimicking colonic polyposis.
Hernández-Évole H, Soy G, Mozas PJ, Araujo IK, Fernández-Esparrach G. Hernández-Évole H, et al. Among authors: mozas pj. Gastrointest Endosc. 2023 Jun;97(6):1165-1166. doi: 10.1016/j.gie.2023.01.030. Epub 2023 Jan 20. Gastrointest Endosc. 2023. PMID: 36682422 No abstract available.
42 results